BIG
COGT icon

Brooklyn Investment Group’s Cogent Biosciences COGT Stock Holding History

Brooklyn Investment Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,099
Closed -$43.8K – 1092
2025
Q2 		$43.8K Buy
6,099
+5,783
+1,830% +$32.1K 0.01% 1406
2025
Q1 		$1.89K Buy
+316
New +$2.48K ﹤0.01% 2173

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Brooklyn Investment Group's COGT Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 6,099 shares — an estimated $43.8K sold.

Brooklyn Investment Group first reported a position in COGT in Q1 2025 and held it in 2 quarters. The position peaked at $43.8K in Q2 2025. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 6,099 Cogent Biosciences shares in Q3 2025, an estimated $43.8K.
  • Brooklyn Investment Group first reported a position in Cogent Biosciences in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Cogent Biosciences position peaked at $43.8K in Q2 2025.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.